Colon Cancer Clinical Trials

A listing of Colon Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Chandler Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Gilbert Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Mesa Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Scottsdale Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

California

Long Beach California 90806

Patients are needed to participate in a clinical research study for the treatment of Colon Cancer

Los Angeles California

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Pasadena California

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

San Diego California 92121

A clinical trial seeking patients for a research study for the treatment of Colon Cancer, Colon Adenomas or Colon Polyps

Santa Barbara California

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

View More ▼

Santa Monica California 90404

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Stanford California 94305

A clinical research study of CT perfusion

Colorado

Aurora Colorado

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Colorado Springs Colorado

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Denver Colorado

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Connecticut

New Haven Connecticut 06519

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Delaware

Newark Delaware 19713

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

District of Columbia

Washington District of Columbia 20007

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study for the treatment of Colon Cancer

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colon Cancer

Florida

University of South Florida- Tampa General Hospital
Tampa Florida 33606

A Randomized Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

View More ▼

Additional Locations Florida

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colorectal Neoplasms, Adenocarcinoma of the Colon or Adenocarcinoma of the Rectum

Altamonte Springs Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Miami Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Miami Beach Florida 33140

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Ocala Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Orlando Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Tampa Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Georgia

Memorial University Medical Center
Savannah Georgia 31404

CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

Illinois

Sherman Health
Elgin Illinois 60123

NSABP P-5 Phase III Randomized Study of Adjuvant Rosuvastatin in Patients With Resected Stage I or II Colon Cancer

View More ▼

Niles Illinois

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Indiana

Goshen Indiana 46526

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Lafayette Indiana

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Iowa

Ames Iowa

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Louisiana

New Orleans Louisiana

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Maryland

Baltimore Maryland

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Baltimore Maryland 21205

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Massachusetts

Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Michigan

Detroit Michigan 48201

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Missouri

Jefferson City Missouri

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

St. Louis Missouri

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nebraska

Lincoln Nebraska

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Omaha Nebraska

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nevada

Henderson Nevada

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Las Vegas Nevada

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

New York

The Rockefeller University Hospital
New York New York 10065

Identification of autoantibodies targeting genes implicated in metastatic cancer

View More ▼

Albany New York

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Binghamton New York

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Bronx New York 10461

A clinical research study of Oxaliplatin for the treatment of Colon Cancer or Rectal Cancer